Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
NCT00003683 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00003683 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer |
| Official title | Treatment of Sarcomatous Kidney Cancer That is Metastatic in Adults With Doxorubicin and Ifosfamide. Phase II Study |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | doxorubicin hydrochloride, ifosfamide |
| Enrollment | 40 |
| Start date | Mar 1, 1998 |
| Primary completion | Nov 5, 2000 |
| Completion | Apr 1, 2002 |
| First posted | Jan 27, 2004 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: